1. Home
  2. ELMT vs RGNX Comparison

ELMT vs RGNX Comparison

Compare ELMT & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Elmet Group Co. Common Stock

ELMT

The Elmet Group Co. Common Stock

N/A

Current Price

$19.69

Market Cap

474.9M

Sector

Industrials

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.26

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELMT
RGNX
Founded
1929
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.9M
487.2M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
ELMT
RGNX
Price
$19.69
$7.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
★ $29.00
$21.40
AVG Volume (30 Days)
472.3K
★ 1.1M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.08
EPS
★ 0.10
N/A
Revenue
N/A
★ $10,393,000.00
Revenue This Year
$34.89
N/A
Revenue Next Year
$29.22
$24.01
P/E Ratio
$194.45
★ N/A
Revenue Growth
N/A
★ 126.48
52 Week Low
$12.49
$5.46
52 Week High
$25.46
$16.19

Technical Indicators

Market Signals
Indicator
ELMT
RGNX
Relative Strength Index (RSI) 46.04 44.73
Support Level $17.53 $6.79
Resistance Level $21.38 $7.32
Average True Range (ATR) 2.19 0.59
MACD -0.20 -0.03
Stochastic Oscillator 31.09 15.40

Price Performance

Historical Comparison
ELMT
RGNX

About ELMT The Elmet Group Co. Common Stock

The Elmet Group Co provides precision-engineered components and high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries. The company is organized into two business divisions, Critical Materials Components and Engineered Microwave Products, offering a platform with expertise across interconnected markets. The company operates an integrated engineering-to-production system, covering custom design, development, and processing across Critical Materials and High-Power Microwave. Its Engineered Microwave capabilities helps to deliver tailored microwave energy solutions, while its Critical Materials expertise allows to design reliable solutions for some of the demanding environments in the world.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: